drugset / Trial / NCT00828906

DuoTrav® Eye Drops As Replacement Therapy Program

NCT00828906

Phase 4 Completed 128 enrolled Alcon Research
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).

Timeline

Start
2009-02
Primary completion
2009-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject DuoTrav Unknown Topical